C20H21FN6O
Neat
380.43
Room Temperature
Selitrectinib; LOXO-195; 2097002-61-2; LOXO195; (6R, 15R)-9-fluoro-15-methyl-2, 11, 16, 20, 21, 24-hexazapentacyclo[16.5.2.02, 6.07, 12.021, 25]pentacosa-1(24), 7(12), 8, 10, 18(25), 19, 22-heptaen-17-one; 0J45910S3X; BAY 2731954; (13E, 14E, 22R, 6R)-35-fluoro-6-methyl-7-aza-1(5, 3)-pyrazolo[1, 5-a]pyrimidina-3(3, 2)-pyridina-2(1, 2)-pyrrolidinacyclooctaphan-8-one; selitrectinibum; LOXO 195; (13E, 14E, 22R, 6R)-35-fluoro-6-methyl-7-aza-1(5, 3)-pyrazolo(1, 5-a)pyrimidina-3(3, 2)-pyridina-2(1, 2)-pyrrolidinacyclooctaphan-8-one; (6R, 15R)-9-fluoro-15-methyl-2, 11, 16, 20, 21, 24-hexazapentacyclo(16.5.2.02, 6.07, 12.021, 25)pentacosa-1(24), 7(12), 8, 10, 18(25), 19, 22-heptaen-17-one; RefChem:182327; TRK Inhibitor LOXO-195; (6R, 15R)-9-fluoro-15-methyl-2, 11, 16, 20, 21, 24-hexaazapentacyclo(16.5.2.0^(2, 6).0^(7, 12).0^(21, 25))pentacosa-1(24), 7(12), 8, 10, 18(25), 19, 22-heptaen-17-one; LOXO 195(Selitrectinib); Selitrectinib (LOXO-195); (3aR, 10R)-5-Fluoro-1, 2, 3, 3a, 8, 9, 10, 11-octahydro-10-methyl-12H-15, 17-ethenopyrazolo[3, 4-d]pyrido[2, 3-k]pyrrolo[2, 1-m][1, 3 and 7]triazacyclotridecin-12-one; Selitrectinib(LOXO-195); MFCD31620755
(6R, 15R)-9-fluoro-15-methyl-2, 11, 16, 20, 21, 24-hexazapentacyclo[16.5.2.02, 6.07, 12.021, 25]pentacosa-1(24), 7(12), 8, 10, 18(25), 19 and 22-heptaen-17-one
InChI=1S/C20H21FN6O/c1-12-4-5-16-14(9-13(21)10-22-16)17-3-2-7-26(17)18-6-8-27-19(25-18)15(11-23-27)20(28)24-12/h6,8-12,17H,2-5,7H2,1H3,(H,24,28)/t12-,17-/m1/s1